Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

22.61USD
17 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$22.61
Open
$23.41
Day's High
$23.80
Day's Low
$22.60
Volume
231,059
Avg. Vol
214,390
52-wk High
$41.75
52-wk Low
$21.38

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.887
Jun '18 0.00 -0.908
Mar '18 0.00 -0.924
FY 2017 Dec '17 0.00 -0.281
Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 5 0.00 0.00 0.00 0.00
Quarter Ending Jun-19 5 0.00 0.00 0.00 0.00
Year Ending Dec-19 11 21.73 142.01 0.00 40.33
Earnings (per share)
Quarter Ending Mar-19 6 -0.89 -0.73 -0.97 -0.83
Quarter Ending Jun-19 6 -0.90 -0.73 -0.99 -0.84
Year Ending Dec-19 11 -3.44 -1.47 -4.30 -2.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.71
P/E High - Last 5 Yrs. -- 45.02 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta -- 0.90 0.90
Price to Sales (TTM) -- 4.12 6.28
Price to Book (MRQ) 5.40 5.11 5.27
Price to Tangible Book (MRQ) 5.41 5.85 6.79
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions 85.47 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.30 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 4.14 5.87
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -49.09 45.04 47.26
EPS (TTM) vs TTM 1 Yr. Ago -44.88 -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -- 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.26
Current Ratio (MRQ) 13.45 2.98 3.08
LT Debt to Equity (MRQ) 0.00 8.86 11.38
Total Debt to Equity (MRQ) 0.00 12.90 16.13
Interest Coverage (TTM) -- 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.65 53.78
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.95 12.88
Operating Margin (TTM) -- 14.28 6.20
Operating Margin - 5 Yr. Avg. -- 14.22 8.32
Pre-Tax Margin (TTM) -- 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 8.62
Net Profit Margin (TTM) -- 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 959,798,993 844,239,900
Net Income/Employee (TTM) -1,529,406 113,819,317 100,064,185
Receivable Turnover (TTM) -- 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) 0.00 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.75 11.55 11.08
Return on Assets - 5 Yr. Avg. -- 12.93 12.21
Return on Investment (TTM) -50.47 14.98 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 15.88
Return on Equity (TTM) -50.82 16.31 15.99
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.22 5.45 99 22
13 Week 22.10 16.15 99 39
26 Week 26.67 17.04 99 33
52 Week 53.60 30.19 99 9
YTD 24.01 8.91 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 80.48%
# of Holders: 199
Total Shares Held: 49,874,905
3 Mo. Net Change: 67,139
# New Positions: 4
# Closed Positions: 2
# Increased Positions: 8
# Reduced Positions: 10
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.